日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

肿瘤微环境来源的S100A8/A9是一种新型的预后生物标志物,可用于晚期黑色素瘤患者以及接受抗PD-1抗体免疫治疗的患者。

Wagner, Nikolaus B; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival

CD74 调节脑转移中肿瘤细胞 HLA II 类肽组的复杂性,是患者生存的积极预后标志物

P S Zeiner, J Zinke, D J Kowalewski, S Bernatz, J Tichy, M W Ronellenfitsch, F Thorsen, A Berger, M T Forster, A Muller, J P Steinbach, R Beschorner, J Wischhusen, H M Kvasnicka, K H Plate, S Stefanović, B Weide, M Mittelbronn, P N Harter

Predictors of responses to immune checkpoint blockade in advanced melanoma

晚期黑色素瘤对免疫检查点阻断反应的预测因素

N Jacquelot, M P Roberti, D P Enot, S Rusakiewicz, N Ternès, S Jegou, D M Woods, A L Sodré, M Hansen, Y Meirow, M Sade-Feldman, A Burra, S S Kwek, C Flament, M Messaoudene, C P M Duong, L Chen, B S Kwon, A C Anderson, V K Kuchroo, B Weide, F Aubin, C Borg, S Dalle, O Beatrix, M Ayyoub, B Balme, G To

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma

尽管维莫非尼和达拉非尼在黑色素瘤中的临床疗效相似,但对患者淋巴细胞的影响却不同

B Schilling, W Sondermann, F Zhao, K G Griewank, E Livingstone, A Sucker, H Zelba, B Weide, U Trefzer, T Wilhelm, C Loquai, C Berking, J Hassel, K C Kähler, J Utikal, P Al Ghazal, R Gutzmer, S M Goldinger, L Zimmer, A Paschen, U Hillen, D Schadendorf; DeCOG